Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

The Direct Anti-Tumor Activity of Enzastaurin (LY317615.HCl) and Its Primary Metabolite (LY326020.HCl) Is Evident in Preclinical DLBCL Models Regardless of Molecular Subtype

Jeremy R Graff, PhD, Ann M McNulty, MS, Chad Dumstorf, PhD, Bruce Konicek, MS, Chad Hall, PhD, Stephen Parsons, MS

Blood (2012) 120 (21): 1336.

https://doi.org/10.1182/blood.V120.21.1336.1336

Published: 2012

Journal Articles

C1GALT1C1 ( COSMC ) Mutations in Four Individuals with Tn+ Phenotype.

Vanja Karamatic Crew, PhD, Carole Green, FIBMS, Stephen Parsons, PhD, Belinda K. Singleton, PhD, Geoff Daniels, PhD, David J. Anstee, PhD

Blood (2007) 110 (11): 1727.

https://doi.org/10.1182/blood.V110.11.1727.1727

Published: 2007

Journal Articles

Targeted Gene Deletion Demonstrates That Adhesion Molecule ICAM-4 Is Critical for Erythroblastic Island Formation.

Gloria Lee, Annie Lo, Sarah Short, Tosti Mankelow, PhD, Stephen Parsons, PhD, Frances Spring, PhD, Narla Mohandas, DSc, David Anstee, PhD, Joel Anne Chasis, MD

Blood (2005) 106 (11): 1661.

https://doi.org/10.1182/blood.V106.11.1661.1661

Published: 2005

Journal Articles

Adhesion Molecule ICAM-4 Participates in Erythroblastic Island Formation.

Gloria Lee, Annie Lo, Sarah Short, Tosti Mankelow, Ph.D., Stephen Parsons, Ph.D., Frances Spring, Ph.D., Mohandas Narla, Ph.D., David Anstee, Ph.D., Joel Anne Chasis, M.D.

Blood (2004) 104 (11): 580.

https://doi.org/10.1182/blood.V104.11.580.580

Published: 2004

Journal Articles

Inhibiting Binding of Sickle Red Cell ICAM-4 to Endothelial Cell αVβ3 Integrin Decreases Red Cell Adhesion and Vaso-Occlusion.

Dhananjay Kaul, Ph.D., Xiao-du Liu, M.D., Xiaoqin Zhang, M.S., Tosti Mankelow, Ph.D., Stephen Parsons, Ph.D., Frances Spring, Ph.D., Xiuli An, Ph.D., Narla Mohandas, Ph.D., David Anstee, Ph.D., Joel Anne Chasis, M.D.

Blood (2004) 104 (11): 361.

https://doi.org/10.1182/blood.V104.11.361.361

Published: 2004

NARROW

The Direct Anti-Tumor Activity of Enzastaurin (LY317615.HCl) and Its Primary Metabolite (LY326020.HCl) Is Evident in Preclinical DLBCL Models Regardless of Molecular Subtype

C1GALT1C1 ( COSMC ) Mutations in Four Individuals with Tn+ Phenotype.

Targeted Gene Deletion Demonstrates That Adhesion Molecule ICAM-4 Is Critical for Erythroblastic Island Formation.

Adhesion Molecule ICAM-4 Participates in Erythroblastic Island Formation.

Inhibiting Binding of Sickle Red Cell ICAM-4 to Endothelial Cell αVβ3 Integrin Decreases Red Cell Adhesion and Vaso-Occlusion.

Email alerts

ASH Publications

American Society of Hematology

The Direct Anti-Tumor Activity of Enzastaurin (LY317615.HCl) and Its Primary Metabolite (LY326020.HCl) Is Evident in Preclinical DLBCL Models Regardless of Molecular Subtype

C1GALT1C1 ( COSMC ) Mutations in Four Individuals with Tn+ Phenotype.

Targeted Gene Deletion Demonstrates That Adhesion Molecule ICAM-4 Is Critical for Erythroblastic Island Formation.

Adhesion Molecule ICAM-4 Participates in Erythroblastic Island Formation.

Inhibiting Binding of Sickle Red Cell ICAM-4 to Endothelial Cell αVβ3 Integrin Decreases Red Cell Adhesion and Vaso-Occlusion.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only